Inside the push to 'decriminalize' psychedelic drug use in New York
The proposal follows Trump’s order to speed federal research and access, as advocates cite rising mental health needs and veteran demand for alternatives.
9 Articles
9 Articles
Senate Committee Weighs “Critical” VA-focused Psychedelics Bill
On April 29, the Senate Veterans’ Affairs Committee held a hearing to consider the bipartisan Veterans Health Administration (VHA) Novel Therapeutics Preparedness Act of 2026. The measure would establish a central authority to oversee the research and implementation of emerging mental health treatments, including psychedelic-assisted therapies. The bill, introduced in March by Senators Tim Sheehy (R-MT) and Ruben Gallego (D-AZ), would require t…
Opening The Door: Why Psychedelics Alone Won’t Save Veterans — And What Must Be Built Around Them - Armed Forces Press
Image by DMTrott This past weekend, on April 18, 2026, President Trump signed an executive order aimed at accelerating research and access to psychedelic therapies for serious mental illness, placing veterans at the center of the effort. Substances once pushed to the margins—psilocybin, MDMA, ibogaine—are now being discussed at the highest levels of government as potential tools to address PTSD, depression, addiction, and suicide. On its face, t…
Federal agencies’ next moves to accelerate the availability of psychedelic therapies
In the wake of President Donald Trump’s historic executive order on April 18 to accelerate access to psychedelic therapies, federal agencies have quickly responded with a series of related announcements. On April 24, the U.S. Food and Drug Administration (FDA) issued priority vouchers for psilocybin and methylone as treatments for serious forms of depression and post-traumatic stress disorder (PTSD), respectively. The agency also approved a Phas…
Senate Committee Takes Up Veterans-Focused Psychedelics Bill, With VA Officials Expressing Concerns
A U.S. Senate committee is taking up a bipartisan bill to promote research into the therapeutic potential psychedelics by creating a new office focused on the issue in the Department of Veterans Affairs (VA)-hearing testimony from federal officials and veterans groups about the measure. Representatives from VA testified that despite aligning with the "intent" of the bill, the department does not support the legislation itself and "does not belie…
Coverage Details
Bias Distribution
- 40% of the sources lean Left, 40% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium





